Skip to content

EXOZ EXOZ Return on assets

Return on assets at other companies

Gevo logo
GevoGEVO
-4.9%-1.8pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-26.2%-4.4pp
NAG
Niagen Bioscience, Inc. Common StockNAGE
19%-1.8pp
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
7.7%+3.6pp
Opko Health logo
Opko HealthOPK
-10.7%-13.6pp
Upexi logo
UpexiUPXI
-212.1%-367pp

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-3.3%
Enterprise value$76.57M+3.5%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

Based on trailing twelve months.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's return on assets?
EXOZ (EXOZ) reported return on assets of -124.4% in Q1 2026.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.